Morbidity of Breast Cancer Patients Following Complete Axillary Dissection or Sentinel Node Biopsy Only: A Comparative Evaluation

A. Haid1, Roswitha Köberle‐Wührer1, Michael Knauer1, Judit Burtscher1, H Fritzsche2, William Peschina2, Zerina Jasarevic3, Maria Ammann3, Klaus Hergan4, Heinz Sturn5, G. Zimmermann1
1Department of General and Thoracic Surgery, Akademisches Lehrkrankenhaus der Universität Innsbruck, Feldkirch, Austria
2Department of Nuclear Medicine, Akademisches Lehrkrankenhaus der Universität Innsbruck, Feldkirch, Austria
3Institute of Pathology, Akademisches Lehrkrankenhaus der Universität Innsbruck, Feldkirch, Austria
4Central Radiology Service, Akademisches Lehrkrankenhaus der Universität Innsbruck, Feldkirch, Austria
5Landeskrankenhaus Feldkirch, Akademisches Lehrkrankenhaus der Universität Innsbruck, Feldkirch, Austria

Tóm tắt

Từ khóa


Tài liệu tham khảo

Giuliano AE, Kirgan DM, Guenther MJ, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220(3): 391–401, 1994

Giuliano AE, Dale PS, Turner RR, Morton DL, Evans Sheila W, Krasne DL: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222(3): 394–401, 1995

Haid A, Fritzsche H, Peschina W, Gruber-Mösenbacher U, Jasarevic S, Hillbrand E, Köberle-Wührer R, Müller G, Schmidle T, Breitfellner G: Die Sentinel-Node-Biopsy beim Mammakarzinom: ein minimal invasives Verfahren zum exakten Staging der Axilla. Wien Klin Wochenschr111/6: 219–225, 1999

Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, Robertson C, Orvieto E, De Cicco C, Intra M, Tosi G, Scarpa D: Sentinel node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 91: 368–373, 1999

Wührer-Köberle R, Haid A, Eiter H, Zimmermann G: Zur Morbidität der Axilladissektion beim Mammakarzinom. In: Waclawiczek HW, Menzel Ch, Hausmanninger H, Kogelnik HD, Wolf G (eds) Die interdisziplinäre kurative Behandlung des Mammakarzinoms. Was ist Standard, was ist Routine? Barth, Heidelberg Leipzig, 1998

Hack TF, Cohen L, Katz J, Robson LS, Goss P: Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 17(1): 143–149, 1999

Schrenk P, Riegler M, Shamiyeh A, Wayand W: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88: 608–614, 2000

Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, Glass EC, Turner R: Prospective observational study of sentinel lymphadenectomy without axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18: 2553–2559, 2000

Kissin MW, Querci della Rovere G, Easton D, Westbury G: Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73: 580–584, 1986

Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT: Assessment of morbidity from complete axillary dissection. Br J Surg 66: 136–138, 1992

Liljegren G, Holmberg L: Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage 1. Results from a randomised trial. Uppsala-Örebro Breast Cancer Study Group. Eur J Cancer 33(2): 193–199, 1997

Kjaergaard J, Blichert-Toft M, Andersen JA, Rank F, Pedersen PV: Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer. Br J Surg 72: 365–367, 1985

Senofsky GM, Moffat Jr FL, Davis K, Masri MM, Clark KC, Robinson DS, Sabates B, Ketcham AS: Total axillary lymphadenektomy in the management of breast cancer. Arch Surg 126: 1336–1342, 1991

Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152: 765–772, 1981

Turner RR, Ollila DW, Krasne DL, Giuliano AE: Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226: 271–278, 1997

Haid A, Hergan K, Oser W, Zimmermann G: Wertigkeit der präoperativen Axillasonographie beim Mammakarzinom. Langenbecks Arch Chir Suppl II: 97–100, 1996

Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Maiterth C, Dahlbender R, Wendt I, Kreienberg R: Long-term morbidity following axillary dissection in breast cancer patients-clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 64(3): 275–286, 2000